Blood Group Typing Market Size, Share & Trends Analysis Report By Techniques (PCR-Based and Microarray Technique, Massively Parallel Sequencing, Assay-based Techniques, Others), By Test Type (Human Leukocyte Antigen (HLA) Typing, Antibody Screening, ABO Blood Tests, Cross-matching Series, Antigen Typing), By Products Type (Instruments, Services, Consumables), By End-User (Clinical Laboratories, Blood Banks, Hospitals, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Blood Group Typing Market Size

The global blood group typing market size was valued at USD 2.08 billion in 2025 and is projected to grow from USD 2.27 billion in 2026 to USD 4.55 billion by 2034, registering a CAGR of 9.1% during the forecast period from 2026 to 2034. North America dominated the blood group typing market with a market share of 38.4% in 2025.

Blood group typing is a diagnostic test determining an individual's blood type. Knowing the individual's blood group is crucial because not all blood types are compatible. Blood groups are determined by the antigens found on the surface of red blood cells. Antigens are substances that aid the body in distinguishing between its cells and potentially harmful foreign cells. The ABO system, used in blood type lab tests, divides the blood into four common categories A, B, AB, and O. In addition, the red blood cells' Rh status, which is determined by a second mechanism called the Rh system, is also determined. Those who are carriers of the Rh factor are considered to be Rh+. A mismatch can cause a severe immunogenic reaction that can be fatal. Hence it is crucial to understand both the ABO and Rh types. Blood group typing is frequently performed during pregnancy when tissue transplants and blood transfusions are necessary.

Techniques Insights

The market is bifurcated into PCR-based and microarray techniques, massively parallel sequencing, assay-based techniques, and others. The PCR-based and microarray technique segment dominates the global market and is estimated to exhibit a CAGR of 10.51% over the forecast period. With the help of PCR-based and microarray, medical professionals can resolve weak, indistinguishable, and unexpected serological findings. Blood typing with PCR-based and microarray techniques provides the genetic information in the DNA of the donor or the recipient, which helps to interpret the structure of the antigen on the erythrocyte surface. Blood typing with such techniques offers fast results and cost-effective solutions. Due to such factors, the segment will register rapid growth over the forecast period.

Request Customizationto receive a tailored report.

Test Type Insights

The market is divided into human leukocyte antigen (HLA) typing, antibody screening, ABO blood tests, cross-matching series, and antigen typing. The antibody screening segment is the most significant contributor to the market and is estimated to exhibit a CAGR of 10.50% over the forecast period. Red blood cells carry several carbohydrate and protein antigens on their surface. More than 600 antigens are separated in the system of 30 blood groups. A person exposed to blood with different antigens can form antibodies. In addition, a mandatory test during pregnancy is an antibody screening or antibody test, which checks for any antibody, special proteins made by the immune system, in the blood.

Moreover, the 'type and screen policy' involves the prior determination of the patient's blood group and antibody screening at admission. This provides enough time for the blood banks to arrange blood in an emergency. It also provides several advantages to the patient, clinician, hospital management, and stakeholders. Owing to all these factors, there is an upsurge in the market growth in this segment.

Product Type Insights

The market is divided into instruments, services, and consumables. The consumables segment owns the largest market share and is estimated to exhibit a CAGR of 10.14% over the forecast period. The demand for consumables for blood group typing is increasing rapidly. Factors such as the growth rate of blood donations, increasing need for blood transfusions, and strict regulations for blood tests are triggering the demand for a blood test and blood group typing assay consumables such as antisera reagents, red blood cell reagents, anti-human globulin reagents, blood bank saline, and other test reagents all around the world.

End-User Insights

The market is bifurcated into clinical laboratories, blood banks, hospitals, and others. The blood banks segment dominates the global market and is predicted to grow at a CAGR of 10.29% during the forecast period. The blood banks segment is also one of the majority shareholders owing to the growing number of blood banks, growing awareness about donation, and an increased number of voluntary donors worldwide. The dominance is predominantly due to the high thawing system usage in these blood banks. As stated by the WHO, there are 13,300 blood centers in 169 countries, collecting a total of 106 million donations. The increasing number of these institutes and donations is anticipated to foster overall market growth.

Furthermore, the growing investments by the private sector led to a rise in blood banks in developed and emerging countries. Due to the extensive use of blood type and illness screening services before transfusion therapy, the market for blood banks is predicted to experience significant expansion.

Speak to an Analystto discuss market opportunities.

Regional Insights

North America is the most significant global blood group typing market shareholder and is expected to grow at a CAGR of 9.91% over the forecast period. The global market in the North American region is witnessing high growth due to the surging number of road accidents and the rising prevalence of chronic diseases. The Organization for Safe International Road Travel estimates that over 38,000 persons die on US roads yearly. There are 12.4 road fatalities for every 100,000 people in the United States. Similarly, direct medical expenses from traffic accidents cost the United States more than USD 380 million.

Furthermore, there is a growing demand for blood transfusion in the United States. The American National Red Cross estimates that over 36,000 units of RBCs are required each day and that approximately 21 million blood components are transfused in the United States annually. Blood typing is desperately needed in each of the situations above, and the market will expand as more of these situations arise. The large market share held by several well-known companies in North America is favorable for expanding the global market.

Unlock Regional Insightsto access country-level data, & regional trends.

Europe Blood Group Typing Market Trends

Europe is estimated to exhibit a CAGR of 9.36% over the forecast period. Due to the rapid market expansion in countries like the United Kingdom and France, Europe has a sizable potential for market growth. The driving aspect for the growth of the European global market include the rising prevalence of chronic diseases, increased healthcare spending, and strong R&D initiatives from market players. In addition, Europe is considered the most crucial market for blood group typing services and products due to the presence of various reimbursement ventures for various surgeries and several chronic diseases. As per the Global Cancer Observatory, the number of new incident cancer cases for 2018 was 4.2 million, and the deaths surpassed 1.94 million in Europe. Other factors are also attributed to the increasing incidence of cancer in Europe, i.e., unhealthy lifestyles and unsuitable diets, obesity, and a lack of physical activity. Hence, the rising incidence and prevalence of cancer will expedite the growth of the global market in Europe during the forecast period.

Asia Pacific Blood Group Typing Market Trends

Asia-Pacific is predicted to experience the greatest growth in the blood group typing industry. The market in the region is most expected to be driven by China, India, and Japan. Due to the region's rapidly expanding healthcare sector and the strong demand for blood group typing, mostly from countries with dense populations, this market is anticipated to have enormous growth opportunities. Asia-Pacific is anticipated to exhibit the quickest CAGR because of the increasing prevalence of chronic illnesses requiring blood group typing. The surging incidence of infectious diseases is a major concern in this region, driving the market growth. Furthermore, India ranks 1st in the number of road accident deaths across the 199 republics reported in the World Road Statistics, 2018, followed by China and the US. According to the WHO Global Report on Road Safety 2018, India has almost 11% of the accident-related deaths globally. This, in turn, boosts the global market in the Asia Pacific region.

The RoW comprises the Middle East and Africa, and South America region. The government initiatives for creating awareness regarding proper healthcare facilities also bolstered the demand for blood group typing in the South American region. Rapidly aging South American countries will grow remarkably for the global market. On the other hand, the Egyptian market is expected to develop steadily in the Middle East and African markets throughout the forecasted period owing to the increasing healthcare facility. In addition, rising incidences of cardiothoracic, gastrointestinal, orthopedic, and other diseases that require proper management in a medical facility across the Gulf Cooperation Council countries drive the expansion of the market in the Middle East and Africa region. However, the RoW region is projected to witness a relatively lower CAGR during the projection period because of the shortage of awareness among the general population about blood transfusion safety and the presence of massive underpenetrated markets in these regions.

List of Key and Emerging Players in Blood Group Typing Market